Dear Sir, Please find attached revised outcome of the postal ballot results declared on November 17, 2025, as advised by the exchange.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Procter & Gamble Health Ltd has submitted a revised intimation to BSE regarding the postal ballot results declared on November 17, 2025. Shareholders had approved the appointment of Mr. Shashank Srowthy as an Executive Director of the Company for a period of five years, effective October 1, 2025. Mr. Srowthy is an internal P&G appointee, having joined the company in 2011, with 14 years of experience in finance roles across India, Dubai, and Singapore. The filing includes a confirmation that he is not debarred from directorship by SEBI/MCA and holds no shares in the company.
This is a procedural filing confirming shareholder approval for an internal leadership appointment. No material impact on shareholders or stock price is expected as the appointment was already in effect from October 1, 2025.